- Home
- STT vs WST Comparison
STT vs WST Comparison
Compare STT & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STT
- WST
- Stock Information
- Founded
- STT 1792
- WST 1923
- Country
- STT United States
- WST United States
- Employees
- STT N/A
- WST N/A
- Industry
- STT Major Banks
- WST Medical/Dental Instruments
- Sector
- STT Finance
- WST Health Care
- Exchange
- STT Nasdaq
- WST Nasdaq
- Market Cap
- STT 25.8B
- WST 18.9B
- IPO Year
- STT N/A
- WST N/A
- Fundamental
- Price
- STT $112.42
- WST $253.59
- Analyst Decision
- STT Buy
- WST Buy
- Analyst Count
- STT 12
- WST 7
- Target Price
- STT $117.33
- WST $332.50
- AVG Volume (30 Days)
- STT 1.7M
- WST 575.5K
- Earning Date
- STT 10-14-2025
- WST 10-23-2025
- Dividend Yield
- STT 2.99%
- WST 0.35%
- EPS Growth
- STT 67.51
- WST N/A
- EPS
- STT 8.92
- WST 6.68
- Revenue
- STT $13,323,000,000.00
- WST $2,960,200,000.00
- Revenue This Year
- STT $6.98
- WST $6.28
- Revenue Next Year
- STT $3.62
- WST $6.02
- P/E Ratio
- STT $12.61
- WST $37.92
- Revenue Growth
- STT 10.97
- WST 2.90
- 52 Week Low
- STT $72.81
- WST $187.43
- 52 Week High
- STT $116.37
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- STT 50.71
- WST 56.31
- Support Level
- STT $110.45
- WST $249.94
- Resistance Level
- STT $113.21
- WST $264.06
- Average True Range (ATR)
- STT 1.91
- WST 5.67
- MACD
- STT -0.42
- WST 0.67
- Stochastic Oscillator
- STT 33.28
- WST 53.28
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $47 trillion in assets under custody and administration and $4.7 trillion assets under management as of Dec. 31, 2024, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.